Clonidine ER Dose Range
For ADHD in children and adolescents (6-17 years), clonidine extended-release should be started at 0.1 mg at bedtime and titrated up to a maximum of 0.4 mg/day, typically given in divided doses. 1
Dosing Algorithm
Starting Dose
- Initial: 0.1 mg once daily at bedtime 1
- This minimizes initial sedation and allows assessment of tolerability
Titration Schedule
- Increase by 0.1 mg increments weekly as tolerated 1
- Can advance to twice-daily dosing (morning and bedtime) after initial tolerance established
- Titration period typically spans 3 weeks to reach target dose 2
Target Therapeutic Range
- 0.2-0.4 mg/day total 3, 1
- Most commonly effective doses: 0.2 mg/day or 0.4 mg/day 2, 4
- Maximum recommended: 0.4 mg/day 1
Dosing Frequency
- Can be given once daily (at bedtime) or divided into twice-daily dosing
- Twice-daily administration may provide more consistent symptom control throughout the day
- Taking the larger portion at bedtime reduces daytime sedation 5
Key Clinical Considerations
Efficacy Timeline: Significant ADHD symptom improvement occurs as early as week 2 of treatment and is maintained throughout therapy 2, 4. This relatively rapid onset makes it useful when non-stimulant options are needed.
Common Pitfalls:
- Do not exceed 0.4 mg/day in pediatric ADHD—higher doses increase adverse effects without additional benefit 1
- Never abruptly discontinue—taper gradually to avoid rebound hypertension 1
- Monitor for somnolence (most common side effect), bradycardia, and hypotension 1
- Check baseline and periodic blood pressure and heart rate, especially when combined with other medications affecting cardiac conduction 1
Regional Variations: In South Korea, the maximum approved dose is also 0.4 mg/day 3. In India, dosing is weight-based (0.2-0.4 mg according to weight) 3.
Monotherapy vs. Adjunctive Use
Clonidine ER is approved both as:
- Monotherapy when stimulants are unsuitable, not tolerated, or ineffective
- Adjunctive therapy combined with stimulants for additional symptom control 1, 4
When used adjunctively with stimulants, the same dose range applies (0.1-0.4 mg/day) 4.
Important Safety Warnings
- Cardiovascular monitoring required: Clonidine can cause bradycardia, hypotension, and syncope 1
- Drug interactions: Use caution with other cardiac medications (beta-blockers, calcium channel blockers, digitalis) as additive effects on heart rate and AV conduction can occur 1
- Sedation: Most common adverse effect; warn patients about operating machinery or driving 1
- Withdrawal syndrome: Gradual taper essential to prevent rebound hypertension 1